Hanson McClain Advisors »

4d Molecular Therapeutics In shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.7k 509 9.31
2025-09-30 $3.4k 393 8.69
2025-06-30 $556 150 3.71
2024-06-30 $404 28 14.43
2024-03-31 $893 28 31.89

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds State Street Spd (SPDW)
Spdr Series Trust State Street Spd (SPYG)
Spdr Series Trust State Street Spd (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Index Shs Fds State Street Spd (SPEM)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Ishares Tr Mbs Etf (MBB)
Ishares Tr Usd Inv Grde Etf (USIG)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Gmo Etf Trust Gmo Us Quality E (QLTY)

View all positions for Hanson McClain Advisors

Top funds holding 4d Molecular Therapeutics In

Henderson Group
RA Capital Management
Goldman Sachs Group
BlackRock
Novo A/S
BVF
State Street Corporation
Armistice Capital
Adage Capital Partners GP
Federated Investors
Trails Edge Capital Partners
Geode Capital Management
Bank of America Corporation
Evergreen Quality Fund GP
Deutsche Bank Aktiengesellschaft

View all funds holding 4d Molecular Therapeutics In